• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过抑制鸟氨酸转氨酶来挽救斑马鱼高血氨诱导的毒性。

Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase.

机构信息

University Hospital Heidelberg, Center for Child and Adolescent Medicine, Division for Pediatric Neurology and Metabolic Medicine, Heidelberg, Germany.

Heidelberg Research Center for Molecular Medicine (HRCMM), Heidelberg, Germany.

出版信息

PLoS One. 2018 Sep 10;13(9):e0203707. doi: 10.1371/journal.pone.0203707. eCollection 2018.

DOI:10.1371/journal.pone.0203707
PMID:30199544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6130883/
Abstract

Hyperammonemia is the common biochemical hallmark of urea cycle disorders, activating neurotoxic pathways. If untreated, affected individuals have a high risk of irreversible brain damage and mortality. Here we show that acute hyperammonemia strongly enhances transamination-dependent formation of osmolytic glutamine and excitatory glutamate, thereby inducing neurotoxicity and death in ammoniotelic zebrafish larvae via synergistically acting overactivation of NMDA receptors and bioenergetic impairment induced by depletion of 2-oxoglutarate. Intriguingly, specific and irreversible inhibition of ornithine aminotransferase (OAT) by 5-fluoromethylornithine rescues zebrafish from lethal concentrations of ammonium acetate and corrects hyperammonemia-induced biochemical alterations. Thus, OAT inhibition is a promising and effective therapeutic approach for preventing neurotoxicity and mortality in acute hyperammonemia.

摘要

高血氨症是尿素循环障碍的常见生化特征,会激活神经毒性途径。如果不治疗,受影响的个体有发生不可逆脑损伤和死亡的高风险。在这里,我们表明急性高血氨症强烈增强了依赖转氨作用的渗透调节谷氨酸和兴奋性谷氨酸的形成,从而通过协同过度激活 NMDA 受体和由 2-氧戊二酸耗竭引起的生物能损伤,诱导氨营养型斑马鱼幼虫的神经毒性和死亡。有趣的是,5-氟甲基鸟氨酸对鸟氨酸氨基转移酶(OAT)的特异性和不可逆抑制可使斑马鱼免受致死浓度的乙酸铵的影响,并纠正高血氨症引起的生化改变。因此,OAT 抑制是预防急性高血氨症引起的神经毒性和死亡率的一种有前途且有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/e765830f1a29/pone.0203707.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/a9ce92bb5bec/pone.0203707.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/5b986f452bb6/pone.0203707.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/8c18c05f5be2/pone.0203707.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/15a3fb8a8f44/pone.0203707.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/95ae51af3a21/pone.0203707.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/8ec8922fa33c/pone.0203707.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/29a433d92de8/pone.0203707.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/e765830f1a29/pone.0203707.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/a9ce92bb5bec/pone.0203707.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/5b986f452bb6/pone.0203707.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/8c18c05f5be2/pone.0203707.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/15a3fb8a8f44/pone.0203707.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/95ae51af3a21/pone.0203707.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/8ec8922fa33c/pone.0203707.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/29a433d92de8/pone.0203707.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/6130883/e765830f1a29/pone.0203707.g008.jpg

相似文献

1
Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase.通过抑制鸟氨酸转氨酶来挽救斑马鱼高血氨诱导的毒性。
PLoS One. 2018 Sep 10;13(9):e0203707. doi: 10.1371/journal.pone.0203707. eCollection 2018.
2
Ornithine aminotransferase, a potential target for the treatment of hyperammonemias.鸟氨酸转氨酶,一种治疗高氨血症的潜在靶点。
Curr Drug Targets. 2000 Sep;1(2):119-53. doi: 10.2174/1389450003349254.
3
5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase.5-氟甲基鸟氨酸,一种L-鸟氨酸:2-氧代酸氨基转移酶的不可逆特异性抑制剂。
Biochem J. 1988 Jul 15;253(2):481-8. doi: 10.1042/bj2530481.
4
DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase.DL-犬尿氨酸和5-氟甲基鸟氨酸。鸟氨酸转氨酶的两种失活剂的比较。
Biochem J. 1990 Jun 1;268(2):409-14. doi: 10.1042/bj2680409.
5
Enhanced endogenous ornithine concentrations protect against tonic seizures and coma in acute ammonia intoxication.内源性鸟氨酸浓度升高可预防急性氨中毒时的强直性惊厥和昏迷。
Pharmacol Toxicol. 1993 Feb;72(2):116-23. doi: 10.1111/j.1600-0773.1993.tb00301.x.
6
Effects of ornithine aminotransferase inactivation by 5-fluoromethylornithine in rats following portacaval anastomosis.5-氟甲基鸟氨酸使鸟氨酸转氨酶失活对大鼠门腔静脉吻合术后的影响。
Metab Brain Dis. 1994 Sep;9(3):211-24. doi: 10.1007/BF01991195.
7
Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.鸟氨酸转氨酶抑制对硫代乙酰胺诱导的肝性脑病的影响。
Neurochem Res. 1993 Apr;18(4):539-49. doi: 10.1007/BF00967259.
8
Inhibition of ornithine aminotransferase by 5-fluoromethylornithine: protection against acute thioacetamide intoxication by elevated tissue ornithine levels.5-氟甲基鸟氨酸对鸟氨酸氨基转移酶的抑制作用:通过提高组织鸟氨酸水平预防硫代乙酰胺急性中毒。
Pharmacol Toxicol. 1992 May;70(5 Pt 1):373-80. doi: 10.1111/j.1600-0773.1992.tb00490.x.
9
Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine.与高特异性强效抑制剂5-氟甲基鸟氨酸复合的人鸟氨酸转氨酶的晶体结构。
J Mol Biol. 1999 Jan 8;285(1):297-309. doi: 10.1006/jmbi.1998.2289.
10
Ornithine aminotransferase activity, liver ornithine concentration and acute ammonia intoxication.鸟氨酸转氨酶活性、肝脏鸟氨酸浓度与急性氨中毒
Life Sci. 1989;45(11):1009-19. doi: 10.1016/0024-3205(89)90155-0.

引用本文的文献

1
Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer.鸟氨酸转氨酶支持胰腺癌中的多胺合成。
Nature. 2023 Apr;616(7956):339-347. doi: 10.1038/s41586-023-05891-2. Epub 2023 Mar 29.
2
Zebrafish, an In Vivo Platform to Screen Drugs and Proteins for Biomedical Use.斑马鱼,一种用于生物医学用途的药物和蛋白质筛选的体内平台。
Pharmaceuticals (Basel). 2021 May 24;14(6):500. doi: 10.3390/ph14060500.
3
Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders.

本文引用的文献

1
Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland.尿素循环障碍的发病率、疾病发作及短期转归——德国、奥地利和瑞士的跨境监测
Orphanet J Rare Dis. 2017 Jun 15;12(1):111. doi: 10.1186/s13023-017-0661-x.
2
Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study.静脉注射苯甲酸钠治疗尿素循环障碍的疗效与安全性:一项多中心回顾性研究。
Orphanet J Rare Dis. 2016 Sep 23;11(1):127. doi: 10.1186/s13023-016-0513-0.
3
Pivotal role of glutamine synthetase in ammonia detoxification.
中文译文:细胞溶质尿素循环障碍个体代谢性疾病进程的严重程度调整后新生儿筛查评估。
Mol Genet Metab. 2020 Dec;131(4):390-397. doi: 10.1016/j.ymgme.2020.10.013. Epub 2020 Nov 7.
4
A Great Catch for Investigating Inborn Errors of Metabolism-Insights Obtained from Zebrafish.从斑马鱼中获得的关于代谢性先天缺陷研究的新发现
Biomolecules. 2020 Sep 22;10(9):1352. doi: 10.3390/biom10091352.
5
Long-term effects of medical management on growth and weight in individuals with urea cycle disorders.尿素循环障碍患者医学治疗对生长和体重的长期影响。
Sci Rep. 2020 Jul 20;10(1):11948. doi: 10.1038/s41598-020-67496-3.
6
From genotype to phenotype: Early prediction of disease severity in argininosuccinic aciduria.从基因型到表型:精氨琥珀酸尿症疾病严重程度的早期预测
Hum Mutat. 2020 May;41(5):946-960. doi: 10.1002/humu.23983. Epub 2020 Jan 30.
7
Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.尿素循环障碍患者的诊断和治疗对认知功能的影响。
Ann Neurol. 2019 Jul;86(1):116-128. doi: 10.1002/ana.25492. Epub 2019 May 13.
谷氨酰胺合成酶在氨解毒中的关键作用。
Hepatology. 2017 Jan;65(1):281-293. doi: 10.1002/hep.28852. Epub 2016 Nov 12.
4
Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.2001年至2013年期间63例新生儿期发病的尿素循环障碍患者的临床病程。
Orphanet J Rare Dis. 2016 Aug 19;11(1):116. doi: 10.1186/s13023-016-0493-0.
5
Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders.疾病发作年龄和血氨峰值而非干预变量可预测尿素循环障碍的神经学转归。
J Inherit Metab Dis. 2016 Sep;39(5):661-672. doi: 10.1007/s10545-016-9938-9. Epub 2016 Apr 22.
6
Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders--review and meta-analysis of observational studies published over more than 35 years.早发性尿素循环障碍患儿的新生儿死亡率及1岁末的转归——对35年多来发表的观察性研究的综述与荟萃分析
J Inherit Metab Dis. 2016 Mar;39(2):219-29. doi: 10.1007/s10545-015-9901-1. Epub 2015 Dec 3.
7
Aminoacyl-tRNA synthetase dependent angiogenesis revealed by a bioengineered macrolide inhibitor.一种生物工程大环内酯抑制剂揭示的氨酰-tRNA合成酶依赖性血管生成
Sci Rep. 2015 Aug 14;5:13160. doi: 10.1038/srep13160.
8
Current approaches to enhance glutamate transporter function and expression.增强谷氨酸转运体功能和表达的当前方法。
J Neurochem. 2015 Sep;134(6):982-1007. doi: 10.1111/jnc.13200. Epub 2015 Aug 14.
9
Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.谷氨酸转运体EAAT2:调节、功能及其作为神经和精神疾病治疗靶点的潜力
Cell Mol Life Sci. 2015 Sep;72(18):3489-506. doi: 10.1007/s00018-015-1937-8. Epub 2015 Jun 2.
10
Induction of Phosphoenolpyruvate Carboxykinase (PEPCK) during Acute Acidosis and Its Role in Acid Secretion by V-ATPase-Expressing Ionocytes.急性酸中毒期间磷酸烯醇丙酮酸羧激酶(PEPCK)的诱导及其在表达V-ATP酶的离子细胞酸分泌中的作用。
Int J Biol Sci. 2015 May 1;11(6):712-25. doi: 10.7150/ijbs.11827. eCollection 2015.